Forte Biosciences (FBRX) News Today $7.68 -1.42 (-15.60%) Closing price 04:00 PM EasternExtended Trading$7.65 -0.03 (-0.39%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest UpdateForte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 28,300 shares, a decrease of 79.0% from the January 31st total of 134,600 shares. Based on an average daily volume of 546,400 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.6% of the company's stock are short sold.February 28 at 4:25 PM | marketbeat.comForte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX)Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders bought 30,205 call options on the stock. This represents an increase of approximately 1,663% compared to the average daily volume of 1,713 call options.February 20, 2025 | marketbeat.comOne Forte Biosciences Insider Raised Stake By 273% In Previous YearFebruary 19, 2025 | finance.yahoo.comForte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock traders acquired 30,205 call options on the stock. This represents an increase of approximately 1,663% compared to the average volume of 1,713 call options.February 6, 2025 | marketbeat.comForte Biosciences, Inc. to Present at Upcoming Investor MeetingsFebruary 3, 2025 | finance.yahoo.comTD Cowen Initiates Coverage of Forte Biosciences (FBRX) with Buy RecommendationJanuary 22, 2025 | msn.comForte Biosciences initiated with a Buy at TD CowenJanuary 21, 2025 | markets.businessinsider.comTD Cowen initiates Forte Biosciences stock with Buy ratingJanuary 21, 2025 | msn.comAntony A. Riley Purchases 22,514 Shares of Forte Biosciences, Inc. (NASDAQ:FBRX) StockNovember 23, 2024 | insidertrades.comForte Biosciences (NASDAQ:FBRX) Stock, Short Interest ReportNovember 22, 2024 | benzinga.comForte Biosciences More Than Doubles on $53M Private PlacementNovember 21, 2024 | marketwatch.comForte Biosciences trading halted, volatility trading pauseNovember 21, 2024 | markets.businessinsider.comForte Biosciences Secures $53M for FB102 AdvancementsNovember 21, 2024 | markets.businessinsider.comForte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes WildNovember 21, 2024 | msn.comForte Biosciences Inc. Reports Q3 2024 EarningsNovember 15, 2024 | markets.businessinsider.comForte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short InterestForte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) saw a significant growth in short interest in August. As of August 15th, there was short interest totalling 23,400 shares, a growth of 157.1% from the July 31st total of 9,100 shares. Based on an average daily volume of 72,000 shares, the short-interest ratio is currently 0.3 days.August 28, 2024 | marketbeat.comForte Biosciences Inc (37TA.MU)August 28, 2024 | au.finance.yahoo.com37TA.SG,0P0001K59E,0 (37TA.SG)August 28, 2024 | au.finance.yahoo.comForte Biosciences Inc (37TA.BE)August 28, 2024 | nz.finance.yahoo.comForte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business UpdateAugust 15, 2024 | businesswire.comIs Forte Biosciences, Inc. (FBRX) One of the Best Penny Stocks to Buy Now Under $1?July 15, 2024 | insidermonkey.comCompanies Like Forte Biosciences (NASDAQ:FBRX) Could Be Quite RiskyMay 21, 2024 | finance.yahoo.comForte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesMay 17, 2024 | businesswire.comFBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024May 13, 2024 | investorplace.comForte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business UpdateMay 13, 2024 | businesswire.comForte Biosciences Stock (NASDAQ:FBRX), Analyst Ratings, Price Targets, PredictionsApril 10, 2024 | benzinga.comBuy Recommendation for Forte Biosciences on Strong Potential of Novel FB-102 Treatment and Market PositionApril 8, 2024 | markets.businessinsider.comFBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023March 19, 2024 | investorplace.comForte Biosciences, Inc. Announces 2023 Results and Provides Business UpdateMarch 18, 2024 | businesswire.comForte Biosciences Inc Ordinary SharesDecember 12, 2023 | morningstar.comWe Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth CarefullyDecember 9, 2023 | finance.yahoo.comForte Biosciences Inc Ordinary Shares FBRXNovember 15, 2023 | morningstar.comForte Biosciences GAAP EPS of -$0.26November 14, 2023 | msn.comForte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business UpdateNovember 13, 2023 | finance.yahoo.comISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual MeetingSeptember 14, 2023 | benzinga.comISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual MeetingSeptember 14, 2023 | finance.yahoo.comConcerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s BoardroomSeptember 6, 2023 | finance.yahoo.comConcerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to StockholdersAugust 25, 2023 | businesswire.comCamac Fund Now Owns 4.3% of Forte BiosciencesAugust 25, 2023 | 247wallst.comForte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business UpdateAugust 14, 2023 | finance.yahoo.comChief Financial Officer At This Health Care Company Buys $149K of StockAugust 3, 2023 | benzinga.comForte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102August 1, 2023 | finance.yahoo.comThis Forte Biosciences Insider Increased Their Holding In The Last YearJuly 4, 2023 | finance.yahoo.comWe're Not Very Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn RateMay 24, 2023 | finance.yahoo.comForte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing RulesMay 19, 2023 | finance.yahoo.comForte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business UpdateMay 15, 2023 | finance.yahoo.comUnusual Call Option Trade in Forte Biosciences (FBRX) Worth $2.50KApril 6, 2023 | msn.comForte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business UpdateMarch 31, 2023 | finance.yahoo.comFBRX Forte Biosciences, Inc.January 28, 2023 | seekingalpha.comOne Forte Biosciences, Inc. (NASDAQ:FBRX) insider upped their stake by 7.8% in the previous yearJanuary 25, 2023 | finance.yahoo.com Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address FBRX Media Mentions By Week FBRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBRX News Sentiment▼1.590.71▲Average Medical News Sentiment FBRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBRX Articles This Week▼30▲FBRX Articles Average Week Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SEPN News Today SOPH News Today CMPS News Today BTMD News Today TNGX News Today DRUG News Today CGC News Today ELDN News Today ALMS News Today BNTC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBRX) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
